A BILL 
To amend the Federal Food, Drug, and Cosmetic Act with 
respect to improving the infant formula supply chain, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Babies Need More 
4
Formula Now Act of 2022’’. 
5
SEC. 2. DEFINITION. 
6
In this Act, the term ‘‘infant formula’’ has the mean-
7
ing given to such term in section 201 of the Federal Food, 
8
Drug, and Cosmetic Act (21 U.S.C. 321). 
9
22:43 May 24, 2022
H7830
2 
•HR 7830 IH
SEC. 3. IMPORTATION OF INFANT FORMULA. 
1
(a) WAIVER OF LABELING REQUIREMENTS FOR IM-
2
3
metic Act (21 U.S.C. 350a) is amended by adding at the 
4
end the following: 
5
‘‘(j) WAIVER OF LABELING REQUIREMENTS FOR IM-
6
7
‘‘(1) IN GENERAL.—The Secretary may waive 
8
any labeling requirement under this Act applicable 
9
to— 
10
‘‘(A) the importation of infant formula 
11
from any country that is determined by the 
12
Secretary to be implementing and enforcing re-
13
quirements for infant formula that provide a 
14
similar assurance of safety as the regulatory re-
15
quirements of this Act; or 
16
‘‘(B) the distribution and sale of such im-
17
ported infant formula. 
18
‘‘(2) RULE
OF
CONSTRUCTION.—Nothing in 
19
paragraph (1) shall be construed to limit the author-
20
ity of the Secretary to require a recall of, or other-
21
wise impose restrictions and requirements under this 
22
Act with respect to, infant formula that is subject to 
23
a waiver under paragraph (1).’’. 
24
(b) HARMONIZATION.—The Secretary of Health and 
25
Human Services shall, when appropriate, enter into ar-
26
22:43 May 24, 2022
H7830
3 
•HR 7830 IH
rangements with other nations for the purpose of harmo-
1
nizing the regulatory requirements of the United States 
2
for infant formula, including with respect to inspections, 
3
nutritional requirements, and common international label-
4
ing, with the corresponding regulatory requirements of 
5
such other nations. 
6
(c) SUPPORT
FOR
THE OFFICE
OF
THE UNITED 
7
STATES TRADE REPRESENTATIVE.—Section 803(c)(2) of 
8
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
9
383(c)(2)) is amended by striking ‘‘foods’’ and inserting 
10
‘‘foods (including infant formula)’’. 
11
(d) STUDY.—The Secretary of Health and Human 
12
Services shall enter into an arrangement with the National 
13
Academy of Medicine (or, if the National Academy de-
14
clines to enter into such arrangement, another appropriate 
15
entity) under which the National Academy (or other ap-
16
propriate entity) agrees to— 
17
(1) conduct a study comparing infant formula 
18
in the United States and infant formula in the Eu-
19
ropean Union, including with respect to nutritional 
20
content and applicable labeling and other regulatory 
21
requirements; and 
22
(2) not later than 1 year after the date of en-
23
actment of this Act, complete such study and submit 
24
a report on the results of such study to the Com-
25
22:43 May 24, 2022
H7830
4 
•HR 7830 IH
mittee on Energy and Commerce of the House of 
1
Representatives and the Committee on Health, Edu-
2
cation, Labor, and Pensions of the Senate. 
3
SEC. 4. TRANSPARENCY TO SUPPORT INFANT FORMULA IN-
4
NOVATION. 
5
(a) ANNUAL REPORT TO CONGRESS.—Section 412 of 
6
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
7
350a), as amended by section 3(a) of this Act, is further 
8
amended by adding at the end the following: 
9
‘‘(k) ANNUAL REPORT
TO CONGRESS.—Not later 
10
than March 30 of each year, the Secretary shall submit 
11
a report to the Congress containing, with respect to the 
12
preceding calendar year, the following information: 
13
‘‘(1) The number of submissions received by the 
14
Secretary under subsection (d). 
15
‘‘(2) For each such submission— 
16
‘‘(A) the amount of time taken by the Sec-
17
retary to respond; 
18
‘‘(B) the number of times the Secretary re-
19
quested additional information from the person 
20
making such submission; and 
21
‘‘(C) whether such submission included any 
22
new ingredients that were not included in any 
23
infant formula already on the market. 
24
22:43 May 24, 2022
H7830
5 
•HR 7830 IH
‘‘(3) The number of inspections conducted by 
1
the Food and Drug Administration or any agent 
2
thereof to evaluate compliance with subsection 
3
(b)(2). 
4
‘‘(4) The time between any inspection referred 
5
to in paragraph (3) and any necessary reinspection 
6
to evaluate compliance with subsection (b)(2).’’. 
7
(b) MARKETING SUBMISSIONS.—Section 412 of the 
8
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a), 
9
as amended by subsection (a), is further amended by add-
10
ing at the end the following: 
11
‘‘(l) MARKETING SUBMISSIONS.— 
12
‘‘(1) IN GENERAL.—Subject to paragraph (2), 
13
the Secretary shall respond to a submission under 
14
subsection (d) for infant formula not later than 90 
15
days after receiving such notification. 
16
‘‘(2) EXPEDITED
RESPONSE.—The Secretary 
17
shall respond to a submission under subsection (d) 
18
for infant formula not later than 75 days after re-
19
ceiving such notification if it— 
20
‘‘(A) is submitted by a manufacturer that 
21
is not already marketing infant formula in the 
22
United States; or 
23
‘‘(B) is for infant formula containing one 
24
or more ingredients that are not contained in 
25
22:43 May 24, 2022
H7830
6 
•HR 7830 IH
infant formula that is already being marketed 
1
in the United States. 
2
‘‘(3) NOTIFICATION TO CONGRESS.—Whenever 
3
the Secretary fails to respond to a submission under 
4
subsection (d) by the deadline applicable under para-
5
graph (1) or (2), the Secretary shall give notice of 
6
such failure to the Congress, including an expla-
7
nation of the reasons for failing to meet the dead-
8
line.’’. 
9
(c) TECHNICAL CORRECTION.—Section 412(c)(1)(B) 
10
of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
11
350a(c)(1)(B)) is amended by striking ‘‘subsection (c)(1)’’ 
12
and inserting ‘‘subsection (d)(1)’’. 
13
SEC. 5. REDUCING BARRIERS TO INFANT FORMULA COM-
14
PETITION. 
15
Not later than 180 days after the date of enactment 
16
of this Act, the Secretary of Health and Human Services, 
17
acting through the Commissioner of Food and Drugs, 
18
shall issue guidance on which types of changes, if any, in 
19
the ingredients of infant formula may not require a new 
20
growth study to meet the requirements of section 412 of 
21
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
22
350a). 
23
22:43 May 24, 2022
H7830
7 
•HR 7830 IH
SEC. 6. COORDINATION OF EFFORTS TO MITIGATE SHORT-
1
AGES OF INFANT FORMULA. 
2
The Secretary of Health and Human Services, acting 
3
through the Commissioner of Food and Drugs, shall re-
4
quire appropriate staff of the Office of Nutrition and Food 
5
Labeling, and the Office of Compliance, of the Center for 
6
Food Safety and Applied Nutrition, to meet at least bi-
7
weekly to discuss, with respect to infant formula, pending 
8
inspections, the findings of pending and concluded inspec-
9
tions, and any need for additional inspections. 
10
SEC. 7. IMPORTATION FOR PERSONAL USE. 
11
(a) IN GENERAL.—During the period of 90 days fol-
12
lowing the date of enactment of this Act, a person may, 
13
without prior notice to the Food and Drug Administration, 
14
import up to a three-month supply of infant formula for 
15
personal use from Canada, the European Union, or any 
16
country that is determined by the Secretary of Health and 
17
Human Services, acting through the Commissioner of 
18
Food and Drugs, to have safety standards for infant for-
19
mula similar to such standards applicable under the Fed-
20
eral Food, Drug, and Cosmetic Act (21 U.S.C. 301 et 
21
seq.). 
22
(b) LIMITATIONS.—Infant formula may be imported 
23
pursuant to subsection (a) only if the infant formula— 
24
(1) is exclusively for personal use and will not 
25
be commercialized or promoted; and 
26
22:43 May 24, 2022
H7830
8 
•HR 7830 IH
(2) does not present an unreasonable risk to 
1
human health. 
2
(c) REPORTING OF ADVERSE EVENTS.—If a health 
3
care provider becomes aware of any adverse event which 
4
the health care provider reasonably suspects to be associ-
5
ated with infant formula imported pursuant to subsection 
6
(a), the health care provider shall report such adverse 
7
event to the Food and Drug Administration. 
8
(d) PUBLIC NOTICE.—The Secretary of Health and 
9
Human Services, acting through the Commissioner of 
10
Food and Drugs, shall post on the public website of the 
11
Food and Drug Administration notice that— 
12
(1) infant formula imported pursuant to sub-
13
section (a) may not have been manufactured in a fa-
14
cility that has been inspected by the Food and Drug 
15
Administration; 
16
(2) the labeling of such infant formula may not 
17
meet the standards and other requirements applica-
18
ble with respect to infant formula under the Federal 
19
Food, Drug, and Cosmetic Act (21 U.S.C. 301 et 
20
seq.); and 
21
(3) the nutritional content of the infant formula 
22
may vary from that of infant formula meeting such 
23
standards and other requirements. 
24
22:43 May 24, 2022
H7830
9 
•HR 7830 IH
(e) SENSE OF CONGRESS.—It is the sense of Con-
1
gress that persons considering the personal importation of 
2
infant formula should consult with their pediatrician about 
3
such importation. 
4
SEC. 8. CONSIDERATION OF SUPPLY EFFECTS PRIOR TO 
5
RECOMMENDING OR REQUIRING A RECALL. 
6
(a) IN GENERAL.—Section 412(f) of the Federal 
7
Food, Drug, and Cosmetic Act (21 U.S.C. 350a(f)(2)) is 
8
amended by adding at the end the following: 
9
‘‘(4) Before recommending or requiring any recall of 
10
infant formula due exclusively to labeling deficiencies, the 
11
Secretary shall ensure that the supply of infant formula 
12
in the United States will not be negatively affected by such 
13
recall.’’. 
14
(b) REGULATIONS.—Not later than 3 months after 
15
the date of enactment of this Act, the Secretary of Health 
16
and Human Services, acting through the Commissioner of 
17
Food and Drugs, shall issue or update such regulations 
18
as may be necessary to implement paragraph (4) of section 
19
412(f) of the Federal Food, Drug, and Cosmetic Act, as 
20
added by subsection (a). 
21
SEC. 9. CONGRESSIONAL NOTIFICATION. 
22
(a) IN GENERAL.—Not later than 24 hours after the 
23
initiation of a recall of infant formula, the Secretary of 
24
Health and Human Services, acting through the Commis-
25
22:43 May 24, 2022
H7830
10 
•HR 7830 IH
sioner of Food and Drugs, shall submit to the Congress 
1
a notification of such recall. 
2
(b) CONTENTS.—A notification under subsection (a) 
3
shall include the following: 
4
(1) If the recall is required by the Food and 
5
Drug Administration, a summary of the determina-
6
tion of a case of adulterated or misbranded infant 
7
formula that presents a risk to human health. 
8
(2) If the recall is voluntarily initiated by the 
9
manufacturer, a summary of the information pro-
10
vided to the Food and Drug Administration by the 
11
manufacturer regarding infant formula that has left 
12
the control of the manufacturer that may be adulter-
13
ated or misbranded. 
14
(3) Specification of when the Food and Drug 
15
Administration was first made aware of the instance 
16
or circumstances surrounding the recall. 
17
(4) An initial estimate of the disruption in do-
18
mestic production that may result from the recall. 
19
SEC. 10. REPORT TO CONGRESS. 
20
(a) IN GENERAL.—Not later than 14 days after the 
21
initiation of a recall of infant formula, the Secretary of 
22
Health and Human Services, acting through the Commis-
23
sioner of Food and Drugs, shall submit a report to the 
24
Congress regarding such recall. 
25
22:43 May 24, 2022
H7830
11 
•HR 7830 IH
(b) CONTENTS.—A report under subsection (a) shall 
1
include the following: 
2
(1) A plan (including an estimated timeline) of 
3
actions the Food and Drug Administration and the 
4
manufacturer will take— 
5
(A) to identify and address any cause of 
6
adulteration or misbranding; and 
7
(B) to restore operation of the impacted 
8
facilities to meet production levels in place prior 
9
to the recall. 
10
(2) The current domestic supply of infant for-
11
mula, including— 
12
(A) a breakdown of the specific types of 
13
formula involved; and 
14
(B) an estimate of how long current sup-
15
plies will last. 
16
(3) In the case that a recall and subsequent ac-
17
tions to respond to the recall impact over 10 percent 
18
of the domestic production of infant formula, a plan 
19
to backfill supplies if the current domestic supply of 
20
infant formula has or is expected to fall below the 
21
level demanded during the disruption in domestic 
22
production, which plan shall include— 
23
22:43 May 24, 2022
H7830
12 
•HR 7830 IH
(A) actions to work with the impacted 
1
manufacturer or other manufacturers to in-
2
crease production; and 
3
(B) specification of— 
4
(i) any additional authorities needed 
5
regarding production or importation to fill 
6
a supply gap; and 
7
(ii) any supplemental funding nec-
8
essary to address the shortage. 
9
SEC. 11. COORDINATION WITH MANUFACTURER ON RE-
10
STORING PRODUCTION. 
11
(a) IN GENERAL.—Upon completing an inspection of 
12
an infant formula manufacturing facility impacted by a 
13
recall, the Secretary of Health and Human Services, act-
14
ing through the Commissioner of Food and Drugs, shall 
15
provide the manufacturer involved a list of any actions 
16
necessary— 
17
(1) to address deficiencies contributing to the 
18
potential adulteration or misbranding of product at 
19
the facility; and 
20
(2) to safely restart production at the facility. 
21
(b) RESPONSE TO MANUFACTURER.—Not later than 
22
7 days after receiving a written communication from a 
23
manufacturer of infant formula regarding safely restoring 
24
production following a recall of such product, the Sec-
25
22:43 May 24, 2022
H7830
13 
•HR 7830 IH
retary of Health and Human Services, acting through the 
1
Commissioner of Food and Drugs, shall provide a sub-
2
stantive response to such communication, including any 
3
necessary next steps. 
4
Æ 
22:43 May 24, 2022
H7830
